| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.091 | 0.08 |